Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. and Certain Officers - AVXL

GlobeNewswire December 30, 2015

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Anavex Life Sciences Corp. and Strongly Encourages Investors to Contact the Firm

Business Wire December 29, 2015

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Anavex Life Sciences Corp. (AVXL)

PR Newswire December 29, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by Anavex Life Sciences Corp. and Certain Officers and Directors

Business Wire December 29, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Anavex Life Sciences Corp. - AVXL

PR Newswire December 29, 2015

Anavex Announces Fiscal 2015 Year-End Financial Results

GlobeNewswire December 29, 2015

Uplisting: What It Means For These Four (4) Companies

Accesswire December 11, 2015

Innovative Therapies, Diagnostics, and Events Propel These Hot Promising Small Caps

Accesswire December 9, 2015

Anavex to Present at Third Annual MHPAEA Business Roundtable in Washington, D.C.

GlobeNewswire December 7, 2015

Anavex Expands Management Team

GlobeNewswire December 2, 2015

Under Review: New NASDAQ/NYSE Stock Alert

Accesswire December 1, 2015

Independent Research Describes ANAVEX 3-71 as Potent Cognitive Enhancer in Alzheimer's Disease Models

GlobeNewswire November 30, 2015

Anavex Announces Executive Overseeing Regulatory Affairs

GlobeNewswire November 25, 2015

Anavex to Present at American Epilepsy Society Annual Meeting ANAVEX 2-73 Demonstrates Anti-Seizure Effects in Well Established Preclinical Seizure Models

GlobeNewswire November 19, 2015

Anavex Announces Preparation of Regulatory Filings Based on Guidance From the FDA

GlobeNewswire November 18, 2015

Anavex Confirms Data for Phase 2a Alzheimer's Trial for ANAVEX 2-73

GlobeNewswire November 11, 2015

Anavex Announces Positive Primary and Secondary Endpoints Were Achieved in a Phase 2a Clinical Trial of ANAVEX 2-73 in Alzheimer's Disease?

GlobeNewswire November 9, 2015

Anavex Announces CTAD 2015 Abstract

GlobeNewswire November 5, 2015

Anavex Life Sciences Corp. (Nasdaq:AVXL) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire October 29, 2015

Anavex Commences Trading on NASDAQ Today - To Ring Friday's Closing Bell

GlobeNewswire October 28, 2015